Ross Clark

8.3k total citations · 1 hit paper
87 papers, 6.9k citations indexed

About

Ross Clark is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ross Clark has authored 87 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Molecular Biology and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ross Clark's work include Growth Hormone and Insulin-like Growth Factors (64 papers), Diet and metabolism studies (14 papers) and Metabolism, Diabetes, and Cancer (13 papers). Ross Clark is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (64 papers), Diet and metabolism studies (14 papers) and Metabolism, Diabetes, and Cancer (13 papers). Ross Clark collaborates with scholars based in United States, New Zealand and United Kingdom. Ross Clark's co-authors include I. C. A. F. Robinson, Lena Carlsson, Iain C.A.F. Robinson, Deborah L. Mortensen, J. Michael White, Marco Antonio Meraz‐Ríos, Daniel H. Kaplan, Raymond N. DuBois, Kathleen C. F. Sheehan and Erika A Bach and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Ross Clark

86 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway

1996 1.4k citations Ross Clark et al. profile →

Peers

Countries citing papers authored by Ross Clark

Since Specialization

Citations

This map shows the geographic impact of Ross Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Clark more than expected).

Fields of papers citing papers by Ross Clark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Clark. The network helps show where Ross Clark may publish in the future.

Co-authorship network of co-authors of Ross Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Clark. A scholar is included among the top collaborators of Ross Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Clark. Ross Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure 2005 ·Pediatric Nephrology ·Ross Clark	17
2	The Growth Hormone and Insulin-Like Growth Factor Axis 2001 ·Journal of the American Society of Nephrology ·Vincent Roelfsema, Ross Clark	74
3	Echocardiographic assessment of cardiac morphology and function in mutant dwarf rats 2000 ·Growth Hormone & IGF Research ·S. Longobardi, Antonio Cittadini, Hinrik Strömer, Sarah E. Katz, Jessica Grossman, Ross Clark, James P. Morgan, Pamela S. Douglas	12
4	N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats 2000 ·Brain Research ·Jian Guan, Rita Krishnamurthi, Henry J. Waldvogel, Richard L. M. Faull, Ross Clark, Peter D. Gluckman	93
5	Investigation of Recombinant Human Insulin-Like Growth Factor Type I in Thymus Regeneration in the Acute Stage of Experimental FIV Infection in Juvenile Cats 1999 ·AIDS Research and Human Retroviruses ·Jennifer Woo, Gregg A. Dean, Alora LaVoy, Ross Clark, Peter F. Moore	16
6	Angiotensin II blockade followed by growth hormone as adjunctive therapy after experimental myocardial infarction 1998 ·Journal of Cardiac Failure ·Minoru Hongo, (unknown), Nobuaki Tanaka, Lan Mao, M. Dan McKirnan, Ross Clark, Wesley Won, Kenneth R. Chien, John Ross	14
7	Cloning of Two Novel Growth Hormone Transcripts Expressed in Human Placenta¹ 1998 ·The Journal of Clinical Endocrinology & Metabolism ·César Luiz Boguszewski, Per‐Arne Svensson, Thomas Jansson, Ross Clark, Lena Carlsson, Björn Carlsson	42
8	Growth Hormone Secretagogues Stimulate the Hypothalamic-Pituitary-Adrenal Axis and Are Diabetogenic in the Zucker Diabetic Fatty Rat¹ 1997 ·Endocrinology ·Ross Clark, G. B. Thomas, Deborah L. Mortensen, Wesley Won, (unknown), (unknown), Keith M. Fairhall, Iain C. A. F. Robinson	42
9	Consequences of Growth Hormone Deficiency on Cardiac Structure, Function, and β-Adrenergic Pathway: Studies in Mutant Dwarf Rats¹ 1997 ·Endocrinology ·Antonio Cittadini, Hinrik Strömer, Dorothy E. Vatner, Jessica Grossman, Sarah E. Katz, Ross Clark, James P. Morgan, Pamela S. Douglas	21
10	Growth Hormone Attenuates Early Left Ventricular Remodeling and Improves Cardiac Function in Rats With Large Myocardial Infarction 1997 ·Journal of the American College of Cardiology ·Antonio Cittadini, Jessica Grossman, Raffaele Napoli, Sarah E. Katz, Hinrik Strömer, Robert J. Smith, Ross Clark, James P. Morgan, Pamela S. Douglas	126
11	Growth Hormone and Insulin-like Growth Factor 1: New Endocrine Therapies in Cardiology? 1997 ·Trends in Cardiovascular Medicine ·Ross Clark	2
12	The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I 1996 ·Endocrinology ·Ross Clark	14
13	The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I. 1996 ·Endocrinology ·Ross Clark, Deborah L. Mortensen, Lena Carlsson, Björn Carlsson, (unknown), I. C. A. F. Robinson	34
14	Recombinant human growth hormone (GH)-binding protein enhances the growth-promoting activity of human GH in the rat. 1996 ·Endocrinology ·Ross Clark, Deborah L. Mortensen, Lena Carlsson, Steven A. Spencer, Patrick McKay, Michael G. Mulkerrin, Jerome A. Moore, Brian C. Cunningham	56
15	Affinity Purification and Microcharacterization of Recombinant DNA-Derived Human Growth Hormone Isolated from an in Vivo Model 1995 ·Analytical Chemistry ·John E. Battersby, Venkat R. Mukku, Ross Clark, William S. Hancock	18
16	Insulin-like growth factor-1 stimulation of lymphopoiesis. 1993 ·Journal of Clinical Investigation ·Ross Clark, Jane E. Strasser, Susan McCabe, (unknown), Paula Jardieu	147
17	Growth hormone and growth in diabetic rats: effects of insulin and insulin-like growth factor-I infusions 1989 ·Journal of Endocrinology ·Lena Carlsson, Ross Clark, Anna Skottner, I. C. A. F. Robinson	20
18	Growth hormone-deficient dwarfism in the rat: a new mutation 1988 ·Journal of Endocrinology ·H. M. Charlton, Ross Clark, I. C. A. F. Robinson, (unknown), (unknown), C Bugnon, (unknown)	211
19	Paradoxical Growth-Promoting Effects Induced by Patterned Infusions of Somatostatin in Female Rats* 1988 ·Endocrinology ·Ross Clark, I. C. A. F. Robinson	45
20	The response of Merino sheep to various diuretic drugs. 1960 ·Ross Clark	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact